BioMarin Pharmaceutical
BMRN
#1907
Rank
S$13.29 B
Marketcap
S$69.20
Share price
-0.78%
Change (1 day)
-21.86%
Change (1 year)

BioMarin Pharmaceutical (BMRN) - Net assets

Net assets on the balance sheet as of September 2025 : S$7.84 Billion

According to BioMarin Pharmaceutical's latest financial reports the company has S$7.84 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

BioMarin Pharmaceutical - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$S$7.69 B17.6%
2023-12-31$S$6.53 B5.97%
2022-12-31$S$6.17 B7.01%
2021-12-31$S$5.76 B6.16%
2020-12-31$S$5.43 B29.04%
2019-12-31$S$4.20 B3.82%
2018-12-31$S$4.05 B7.93%
2017-12-31$S$3.75 B-6.17%
2016-12-31$S$4.00 B17.89%
2015-12-31$S$3.39 B68.22%
2014-12-31$S$2.01 B18.82%
2013-12-31$S$1.69 B36.78%
2012-12-31$S$1.24 B24.08%
2011-12-31$S$1.00 B8.36%
2010-12-31$S$0.92 B104.26%
2009-12-31$S$0.45 B14.32%
2008-12-31$S$0.39 B46.47%
2007-12-31$S$0.27 B49.55%
2006-12-31$S$0.18 B-240.06%
2005-12-31$-S$0.13 Billion16.3%
2004-12-31$-S$0.12 Billion-155.39%
2003-12-31$S$0.20 B17.1%
2002-12-31$S$0.17 B-42.11%
2001-12-31$S$0.29 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Ultragenyx Pharmaceutical
RARE
S$20.94 M-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
S$8.09 M-99.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-S$0.59 Billion-107.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$111.83 B 1,324.82%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
S$0.29 B-96.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
S$1.19 B-84.81%๐Ÿ‡บ๐Ÿ‡ธ USA